BRIBF
Price
$0.26
Change
-$0.01 (-3.70%)
Updated
May 5 closing price
Capitalization
153.02M
NRSN
Price
$1.91
Change
-$0.07 (-3.54%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
45.58M
60 days until earnings call
Interact to see
Advertisement

BRIBF vs NRSN

Header iconBRIBF vs NRSN Comparison
Open Charts BRIBF vs NRSNBanner chart's image
BRII BIOSCIENCE
Price$0.26
Change-$0.01 (-3.70%)
Volume$12.42K
Capitalization153.02M
NeuroSense Therapeutics
Price$1.91
Change-$0.07 (-3.54%)
Volume$3.4K
Capitalization45.58M
BRIBF vs NRSN Comparison Chart in %
Loading...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRIBF vs. NRSN commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRIBF is a Buy and NRSN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BRIBF: $0.26 vs. NRSN: $1.90)
Brand notoriety: BRIBF and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRIBF: 97% vs. NRSN: 174%
Market capitalization -- BRIBF: $153.02M vs. NRSN: $45.58M
BRIBF [@Biotechnology] is valued at $153.02M. NRSN’s [@Biotechnology] market capitalization is $45.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRIBF’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • BRIBF’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BRIBF and NRSN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRSN’s TA Score shows that 3 TA indicator(s) are bullish.

  • NRSN’s TA Score: 3 bullish, 6 bearish.

Price Growth

BRIBF (@Biotechnology) experienced а 0.00% price change this week, while NRSN (@Biotechnology) price change was -19.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

NRSN is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRIBF($153M) has a higher market cap than NRSN($45.6M). BRIBF YTD gains are higher at: 107.254 vs. NRSN (58.333).
BRIBFNRSNBRIBF / NRSN
Capitalization153M45.6M336%
EBITDAN/A-10.41M-
Gain YTD107.25458.333184%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A344K-
Total DebtN/A19K-
TECHNICAL ANALYSIS
Technical Analysis
NRSN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VFC11.840.23
+1.98%
VF Corp
LADR10.870.02
+0.18%
LADDER CAPITAL Corp
ENB44.78-0.30
-0.67%
Enbridge
ICMB2.78-0.03
-1.07%
Investcorp Credit Management BDC
JACK16.80-0.49
-2.83%
Jack In The Box

BRIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRIBF has been loosely correlated with HLVX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BRIBF jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRIBF
1D Price
Change %
BRIBF100%
N/A
HLVX - BRIBF
55%
Loosely correlated
+2.05%
NRSN - BRIBF
6%
Poorly correlated
-4.04%
VIGL - BRIBF
6%
Poorly correlated
-0.06%
IMMX - BRIBF
6%
Poorly correlated
-3.79%
GNTA - BRIBF
5%
Poorly correlated
+1.81%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
-4.04%
SLRX - NRSN
32%
Poorly correlated
-1.01%
CTMX - NRSN
31%
Poorly correlated
-2.16%
DNLI - NRSN
29%
Poorly correlated
-2.77%
VKTX - NRSN
27%
Poorly correlated
-5.82%
KANT - NRSN
27%
Poorly correlated
+15.88%
More